These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32574685)

  • 1. Ultrasound-responsive lipid microbubbles for drug delivery: A review of preparation techniques to optimise formulation size, stability and drug loading.
    Al-Jawadi S; Thakur SS
    Int J Pharm; 2020 Jul; 585():119559. PubMed ID: 32574685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery.
    Owen J; Crake C; Lee JY; Carugo D; Beguin E; Khrapitchev AA; Browning RJ; Sibson N; Stride E
    Drug Deliv Transl Res; 2018 Apr; 8(2):342-356. PubMed ID: 28299722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S; Winter G; Coester C; Bekeredjian R
    J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Strategies for Magnetic Functionalization of Microbubbles.
    Beguin E; Bau L; Shrivastava S; Stride E
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1829-1840. PubMed ID: 30574777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.
    Wu SY; Chen CC; Tung YS; Olumolade OO; Konofagou EE
    J Control Release; 2015 Aug; 212():30-40. PubMed ID: 26065734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications.
    Upadhyay A; Dalvi SV
    Ultrasound Med Biol; 2019 Feb; 45(2):301-343. PubMed ID: 30527395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon.
    Shekhar H; Palaniappan A; Peng T; Lafond M; Moody MR; Haworth KJ; Huang S; McPherson DD; Holland CK
    Neurotherapeutics; 2019 Jul; 16(3):878-890. PubMed ID: 31020629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems.
    Rudakovskaya PG; Barmin RA; Kuzmin PS; Fedotkina EP; Sencha AN; Gorin DA
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
    Dokania S; Joshi AK
    Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbubbles as ultrasound triggered drug carriers.
    Tinkov S; Bekeredjian R; Winter G; Coester C
    J Pharm Sci; 2009 Jun; 98(6):1935-61. PubMed ID: 18979536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical Characterization of the Shell Composition of PBCA-Based Polymeric Microbubbles.
    Appold L; Shi Y; Rütten S; Kühne A; Pich A; Kiessling F; Lammers T
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28371270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the preparation of sonogenic phospholipids-based microbubbles by using central composite experimental design and response surface methodology.
    Zhao YZ; Lu CT; Mei XG
    Yao Xue Xue Bao; 2008 Aug; 43(8):862-7. PubMed ID: 18956781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering the Acoustic Response and Drug Loading Capacity of PBCA-Based Polymeric Microbubbles with Surfactants.
    Barmin RA; Dasgupta A; Bastard C; De Laporte L; Rütten S; Weiler M; Kiessling F; Lammers T; Pallares RM
    Mol Pharm; 2022 Sep; 19(9):3256-3266. PubMed ID: 35905480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric microbubbles for ultrasonic molecular imaging and targeted therapeutics.
    Xiong X; Zhao F; Shi M; Yang H; Liu Y
    J Biomater Sci Polym Ed; 2011; 22(4-6):417-28. PubMed ID: 21144258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Microbubbles for Theranostics and Its Application in Brain Targeted Drug Delivery].
    Omata D
    Yakugaku Zasshi; 2023; 143(10):785-790. PubMed ID: 37779005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acoustic signature of decaying resonant phospholipid microbubbles.
    Thomas DH; Butler M; Pelekasis N; Anderson T; Stride E; Sboros V
    Phys Med Biol; 2013 Feb; 58(3):589-99. PubMed ID: 23318409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
    Pouton CW
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
    Hu YZ; Zhu JA; Jiang YG; Hu B
    Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of lipid-coated microbubbles.
    Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
    Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.